4.1 Article

The Changing Landscape of Progressive Multifocal Leukoencephalopathy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Anti-JC Virus Antibodies: Implications for PML Risk Stratification

Leonid Gorelik et al.

ANNALS OF NEUROLOGY (2010)

Review Public, Environmental & Occupational Health

Progressive Multifocal Leukoencephalopathy and Newer Biological Agents

Joseph R. Berger

DRUG SAFETY (2010)

Review Clinical Neurology

Alemtuzumab in the treatment of relapsing-remitting multiple sclerosis

Edward J. Fox

EXPERT REVIEW OF NEUROTHERAPEUTICS (2010)

Article Virology

Characterization of JC Human Polyomavirus Infection in a Portuguese Population

Ana Matos et al.

JOURNAL OF MEDICAL VIROLOGY (2010)

Article Public, Environmental & Occupational Health

Progressive Multifocal Leukoencephalopathy Deaths in the USA, 1979-2005

Krista L. Yorita Christensen et al.

NEUROEPIDEMIOLOGY (2010)

Article Immunology

Prevalence of Polyomavirus BK and JC Infection and Replication in 400 Healthy Blood Donors

Adrian Egli et al.

JOURNAL OF INFECTIOUS DISEASES (2009)

Article Medicine, Research & Experimental

Monoclonal antibodies and progressive multifocal leukoencephalopathy

Joseph R. Berger et al.

Editorial Material Medicine, General & Internal

Reemergence of PML in Natalizumab-Treated Patients - New Cases, Same Concerns

Eugene O. Major

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Immunology

JC virus detection in bodily fluids: Clues to transmission

Joseph R. Berger et al.

CLINICAL INFECTIOUS DISEASES (2006)

Article Immunology

Infectious complications associated with alemtuzumab use for lymphoproliferative disorders

Stanley I. Martin et al.

CLINICAL INFECTIOUS DISEASES (2006)

Article Medicine, General & Internal

Costimulation blockade with belatacept in renal transplantation

F Vincenti et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Multidisciplinary Sciences

The human polyomavirus, JCV, uses serotonin receptors to infect cells

GF Elphick et al.

SCIENCE (2004)

Article Medicine, General & Internal

A novel targeted T-cell modulator, efalizumab, for plaque psoriasis

M Lebwohl et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)